Pharmacists' confidence in explaining biosimilars to patients before a nationwide medicine change: A cross-sectional study.

ABSTRACT:

Background

Biosimilars can improve patient access to biological medicines. Although biosimilars have been shown to be equally effective and safe, some patients remain reluctant to transition to biosimilars. Pharmacists may support patients changing to biosimilars and are often at the frontline for dealing with queries and concerns, but their confidence and readiness for this role are unclear.

Objective

This study examines pharmacists' confidence in explaining biosimilars to patients and explores the information they would provide in response to common queries.

Methods

Practicing community, hospital, and primary care pharmacists (N = 142) in New Zealand completed an Internet-based survey on their experience and familiarity with bio-originators and biosimilars, a

SUBMITTER: Gasteiger C 

PROVIDER: S-EPMC9649382 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature